Verona Pharma PLC American Depositary Share (VRNA) Competitors

BeOne Medicines (NASDAQ:ONC) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Is ONC or VRNA more profitable?

Verona Pharma PLC American Depositary Share has a net margin of 0.00% compared to BeOne Medicines' net margin of -9.40%. BeOne Medicines' return on equity of -7.55% beat Verona Pharma PLC American Depositary Share's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	-9.40%	-7.55%	-4.42%
Verona Pharma PLC American Depositary Share	N/A	-69.65%	-28.00%

Do analysts rate ONC or VRNA?

BeOne Medicines currently has a consensus price target of $320.67, indicating a potential upside of 30.62%. Verona Pharma PLC American Depositary Share has a consensus price target of $107.36, indicating a potential upside of 17.75%. Given BeOne Medicines' higher probable upside, equities analysts clearly believe BeOne Medicines is more favorable than Verona Pharma PLC American Depositary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Verona Pharma PLC American Depositary Share	0 Sell rating(s)	0 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer ONC or VRNA?

In the previous week, Verona Pharma PLC American Depositary Share had 3 more articles in the media than BeOne Medicines. MarketBeat recorded 6 mentions for Verona Pharma PLC American Depositary Share and 3 mentions for BeOne Medicines. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.25 beat BeOne Medicines' score of 0.00 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Verona Pharma PLC American Depositary Share	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in ONC or VRNA?

48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 6.6% of BeOne Medicines shares are owned by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility & risk, ONC or VRNA?

BeOne Medicines has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500.

Which has higher valuation & earnings, ONC or VRNA?

Verona Pharma PLC American Depositary Share has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$3.81B	7.06	-$644.79M	-$3.72	-65.99
Verona Pharma PLC American Depositary Share	$42.28M	183.59	-$173.42M	-$2.00	-45.59

Summary

Verona Pharma PLC American Depositary Share beats BeOne Medicines on 9 of the 15 factors compared between the two stocks.